• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX TRACHEOBRONCHIAL; PROSTHESIS, TRACHEAL, EXPANDABLE Back to Search Results
Model Number M00564860
Device Problem Activation Failure (3270)
Patient Problem Hypoxia (1918)
Event Date 07/24/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Although the suspect device has been received, the evaluation has not been completed.Therefore, the cause of the reported malfunction has not been determined.Upon completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental mdr will be filed.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2019 that an ultraflex tracheobronchial stent was to be used to treat a malignant stricture in the airway in the right main trachea during an airway constriction and dilation performed on (b)(6) 2019.Reportedly, the patient's anatomy was not tortuous and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent was fully deployed; however, the stent failed to expand.The stent blocked part of the trachea which caused the patient's oxygen concentration to drop to 68-74.The stent was removed with forceps and another ultraflex tracheobronchial stent was implanted to complete the procedure.Reportedly, the patient received the oxygen up-taking continually for the hypoxia.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Event Description
It was reported to boston scientific corporation on july 25, 2019 that an ultraflex tracheobronchial stent was to be used to treat a malignant stricture in the airway in the right main trachea during an airway constriction and dilation performed on (b)(6) 2019.Reportedly, the patient's anatomy was not tortuous and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent was fully deployed; however, the stent failed to expand.The stent blocked part of the trachea which caused the patient's oxygen concentration to drop to 68-74.The stent was removed with forceps and another ultraflex tracheobronchial stent was implanted to complete the procedure.Reportedly, the patient received the oxygen up-taking continually for the hypoxia.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Problem code 3270 captures the reportable event of stent failed to expand.An ultraflex tracheobronchial covered stent was received for analysis; the delivery system was not returned.Visual examination of the returned device found the stent was deployed and expanded.The stent was measured to be within specification.No other issues with the stent were noted.The reported event of stent failure to expand could not be confirmed as the stent was received deployed and expanded.Based on all available information, the investigation concluded that the most probable cause classification of the reported hypoxia is known inherent risk of device, which indicates that the adverse event is known and documented in the labelling.The investigation concluded that the reported failure to expand was likely due to anatomical or procedural factors such as characteristics of the lesion, handling of the device, the technique used by the user, and normal procedural difficulties encountered during the procedure, which limited the performance of the device.Therefore, the most probable root cause is adverse event related to procedure.A review of the device history record (dhr) was performed and confirmed that this device met all material, assembly, and performance specifications at the time of release for distribution.A labeling review was performed and, from the information available, this device was used per the directions for use (dfu) / product label.Additionally, "oxygen desaturation related to sedation or procedural instrumentation infection" is noted within the dfu as a potential adverse events associated with the use of this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX TRACHEOBRONCHIAL
Type of Device
PROSTHESIS, TRACHEAL, EXPANDABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key8905658
MDR Text Key154715888
Report Number3005099803-2019-04145
Device Sequence Number1
Product Code JCT
Combination Product (y/n)N
PMA/PMN Number
K012883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/08/2019
Device Model NumberM00564860
Device Catalogue Number6486
Device Lot Number0021108479
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2019
Initial Date Manufacturer Received 07/25/2019
Initial Date FDA Received08/19/2019
Supplement Dates Manufacturer Received09/05/2019
Supplement Dates FDA Received10/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
Patient Weight48
-
-